Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers

Proteomics - Clinical Applications

Volumn 7, Issue 9-10, 2013, Pages 618-631

  Ju, Tongzhong ^a   Wang, Yingchun ^a   Aryal, Rajindra P ^a   Lehoux, Sylvain D ^a   Ding, Xiaokun ^a   Kudelka, Matthew R ^a   Cutler, Christopher ^a   Zeng, Junwei ^a   Wang, Jianmei ^a   Sun, Xiaodong ^a   Heimburg Molinaro, Jamie ^a   Smith, David F ^a   Cummings, Richard D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Disease; Glycosylation; IgA nephropathy; Tn antigen

Indexed keywords

GLYCAN; IMMUNOGLOBULIN A1; MUCIN; SIALYL TN ANTIGEN; TN ANTIGEN; UNCLASSIFIED DRUG; SIALOSYL-TN ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; CARBOHYDRATE SYNTHESIS; DISEASE MARKER; GLYCOBIOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TN SYNDROME; ANIMAL; BIOSYNTHESIS; DISEASES; METABOLISM; PROCEDURES;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BIOMARKERS, TUMOR; DISEASE; GLYCOMICS; HUMANS; MUCINS;

EID: 84885932102     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300024     Document Type: Article

References (129)

1. Ju, T., Otto, V. I., Cummings, R. D., The Tn antigen-structural simplicity and biological complexity. Angew. Chem. 2011, 50, 1770-1791.
2. Steentoft, C., Vakhrushev, S. Y., Vester-Christensen, M. B., Schjoldager, K. T. et al., Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered simple cell lines. Nat. Methods 2011, 8, 977-982.
3. Ellies, L. G., Tsuboi, S., Petryniak, B., Lowe, J. B. et al., Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity 1998, 9, 881-890.
4. Homeister, J. W., Thall, A. D., Petryniak, B., Maly, P. et al., The alpha(1, 3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 2001, 15, 115-126.
5. Yeh, J. C., Hiraoka, N., Petryniak, B., Nakayama, J. et al., Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1, 3-N-acetylglucosaminyltransferase. Cell 2001, 105, 957-969.
6. Wilkins, P. P., McEver, R. P., Cummings, R. D., Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J. Biol. Chem. 1996, 271, 18732-18742.
7. Yago, T., Leppanen, A., Carlyon, J. A., Akkoyunlu, M. et al., Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin. J. Biol. Chem. 2003, 278, 37987-37997.
8. Tenno, M., Ohtsubo, K., Hagen, F. K., Ditto, D. et al., Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity. Mol. Cell. Biol. 2007, 27, 8783-8796.
9. Marth, J. D., Grewal, P. K., Mammalian glycosylation in immunity. Nature Rev. Immunol. 2008, 8, 874-887.
10. Daniels, M. A., Hogquist, K. A., Jameson, S. C., Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat. Immunol. 2002, 3, 903-910.
11. Sperandio, M., Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J. 2006, 273, 4377-4389.
12. Xia, L., Ju, T., Westmuckett, A., An, G. et al., Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J. Cell Biol. 2004, 164, 451-459.
13. Wang, Y., Ju, T., Ding, X., Xia, B. et al., Cosmc is an essential chaperone for correct protein O-glycosylation. Proc. Natl. Acad. Sci. USA 2010, 107, 9228-9233.
14. Fu, J., Gerhardt, H., McDaniel, J. M., Xia, B. et al., Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 2008, 118, 3725-3737.
15. Johansson, M. E., Larsson, J. M., Hansson, G. C., The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA 2011, 108(Suppl 1), 4659-4665.
16. Kawashima, H., Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer. Biol. Pharm. Bull. 2012, 35, 1637-1641.
17. An, G., Wei, B., Xia, B., McDaniel, J. M. et al., Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med. 2007, 204, 1417-1429.
18. Fu, J., Wei, B., Wen, T., Johansson, M. E. et al., Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J. Clin. Invest. 2011, 121, 1657-1666.
19. Thomsson, K. A., Holmen-Larsson, J. M., Angstrom, J., Johansson, M. E. et al., Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. Glycobiology 2012, 22, 1128-1139.
20. Larsson, J. M., Karlsson, H., Sjovall, H., Hansson, G. C., A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 2009, 19, 756-766.
21. Gill, D. J., Chia, J., Senewiratne, J., Bard, F., Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J. Cell Biol. 2010, 189, 843-858.
22. Ju, T., Cummings, R. D., A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc. Natl. Acad. Sci. USA 2002, 99, 16613-16618.
23. Ju, T., Cummings, R. D., Protein glycosylation: chaperone mutation in Tn syndrome. Nature 2005, 437, 1252.
24. Ju, T., Aryal, R. P., Stowell, C. J., Cummings, R. D., Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc. J. Cell Biol. 2008, 182, 531-542.
25. Iwai, T., Inaba, N., Naundorf, A., Zhang, Y. et al., Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1, 3-N-acetylglucosa-minyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J. Biol. Chem. 2002, 277, 12802-12809.
26. Berger, E. G., Tn-syndrome. Biochim. Biophys. Acta 1999, 1455, 255-268.
27. Barratt, J., Feehally, J., Smith, A. C., Pathogenesis of IgA nephropathy. Semin. Nephrol. 2004, 24, 197-217.
28. Barratt, J., Smith, A. C., Feehally, J., The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) 2007, 12, 275-284.
29. Lisowska, E., Tn antigens and their significance in oncology. Acta Biochim. Pol. 1995, 42, 11-17.
30. Schjoldager, K. T., Clausen, H., Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family. Biochim. Biophys. Acta 2012, 1820, 2079-2094.
31. Ju, T., Brewer, K., D'Souza, A., Cummings, R. D., Canfield, W. M., Cloning and expression of human core 1 beta1, 3-galactosyltransferase. J. Biol. Chem. 2002, 277, 178-186.
32. Ju, T., Cummings, R. D., Canfield, W. M., Purification, characterization, and subunit structure of rat core 1 Beta1, 3-galactosyltransferase. J. Biol. Chem. 2002, 277, 169-177.
33. Brockhausen, I., Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1999, 1473, 67-95.
34. Lowe, J. B., Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 2002, 186, 19-36.
35. Carlow, D. A., Gossens, K., Naus, S., Veerman, K. M. et al., PSGL-1 function in immunity and steady state homeostasis. Immunol. Rev. 2009, 230, 75-96.
36. Gahmberg, C. G., Autero, M., Hermonen, J., Major O-glycosylated sialoglycoproteins of human hematopoietic cells: differentiation antigens with poorly understood functions. J. Cell. Biochem. 1988, 37, 91-105.
37. Robbe-Masselot, C., Maes, E., Rousset, M., Michalski, J. C., Capon, C., Glycosylation of human fetal mucins: a similar repertoire of O-glycans along the intestinal tract. Glycoconj. J. 2009, 26, 397-413.
38. Ikehara, Y., Kojima, N., Kurosawa, N., Kudo, T. et al., Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2, 6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology 1999, 9, 1213-1224.
39. Tsuji, T., Osawa, T., Carbohydrate structures of bovine submaxillary mucin. Carbohydr. Res. 1986, 151, 391-402.
40. Wang, Y., Jobe, S. M., Ding, X., Choo, H. et al., Platelet biogenesis and functions require correct protein O-glycosylation. Proc. Natl. Acad. Sci. USA 2012, 109, 16143-16148.
41. Ju, T., Lanneau, G. S., Gautam, T., Wang, Y. et al., Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 2008, 68, 1636-1646.
42. Schietinger, A., Philip, M., Yoshida, B. A., Azadi, P. et al., A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science 2006, 314, 304-308.
43. Crew, V. K., Singleton, B. K., Green, C., Parsons, S. F. et al., New mutations in C1GALT1C1 in individuals with Tn positive phenotype. Br. J. Haematol. 2008, 142, 657-667.
44. Mi, R., Song, L., Wang, Y., Ding, X. et al., Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen. J. Biol. Chem. 2012, 287, 41523-41533.
45. Yoo, N. J., Kim, M. S., Lee, S. H., Absence of COSMC gene mutations in breast and colorectal carcinomas. APMIS 2008, 116, 154-155.
46. Aryal, R. P., Ju, T., Cummings, R. D., Tight complex formation between Cosmc chaperone and its specific client non-native T-synthase leads to enzyme activity and client-driven dissociation. J. Biol. Chem. 2012, 287, 15317-15329.
47. Carvalho, P., Stanley, A. M., Rapoport, T. A., Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p. Cell 2010, 143, 579-591.
48. Aryal, R. P., Ju, T., Cummings, R. D., The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase. J. Biol. Chem. 2010, 285, 2456-2462.
49. Moreau, R., Dausset, J., Bernard, J., Moullec, J., [Acquired hemolytic anemia with polyagglutinability of erythrocytes by a new factor present in normal blood]. Bull Mem Soc Med Hop Paris 1957, 73, 569-587.
50. Berger, J., Hinglais, N., [Intercapillary deposits of IgA-IgG]. J. Urol. Nephrol. (Paris) 1968, 74, 694-695.
51. Kiryluk, K., Julian, B. A., Wyatt, R. J., Scolari, F. et al., Genetic studies of IgA nephropathy: past, present, and future. Pediatr. Nephrol. 2010, 25, 2257-2268.
52. Yu, H. H., Chu, K. H., Yang, Y. H., Lee, J. H. et al., Genetics and immunopathogenesis of IgA nephropathy. Clin. Rev. Allergy Immunol. 2011, 41, 198-213.
53. Levy, M., Berger, J., Worldwide perspective of IgA nephropathy. Am. J. Kidney Dis. 1988, 12, 340-347.
54. D'Amico, G., Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am. J. Kidney Dis. 2000, 36, 227-237.
55. Paterson, A. D., Liu, X. Q., Wang, K., Magistroni, R. et al., Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J. Am. Soc. Nephrol. 2007, 18, 2408-2415.
56. Gharavi, A. G., Yan, Y., Scolari, F., Schena, F. P. et al., IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet. 2000, 26, 354-357.
57. Schena, F. P., Cerullo, G., Torres, D. D., Zaza, G. et al., Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations. Contrib. Nephrol. 2007, 157, 80-89.
58. Bisceglia, L., Cerullo, G., Forabosco, P., Torres, D. D. et al., Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am. J. Hum. Genet. 2006, 79, 1130-1134.
59. Beerman, I., Novak, J., Wyatt, R. J., Julian, B. A., Gharavi, A. G., The genetics of IgA nephropathy. Nat. Clin. Pract. Nephrol. 2007, 3, 325-338.
60. Julian, B. A., Novak, J., IgA nephropathy: an update. Curr. Opin. Nephrol. Hypertens. 2004, 13, 171-179.
61. Baenziger, J., Kornfeld, S., Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J. Biol. Chem. 1974, 249, 7270-7281.
62. Mattu, T. S., Pleass, R. J., Willis, A. C., Kilian, M. et al., The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J. Biol. Chem. 1998, 273, 2260-2272.
63. Tarelli, E., Smith, A. C., Hendry, B. M., Challacombe, S. J., Pouria, S., Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr. Res. 2004, 339, 2329-2335.
64. Giannakakis, K., Feriozzi, S., Perez, M., Faraggiana, T., Muda, A. O., Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy. J. Am. Soc. Nephrol. 2007, 18, 3139-3146.
65. Gharavi, A. G., Moldoveanu, Z., Wyatt, R. J., Barker, C. V. et al., Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J. Am. Soc. Nephrol. 2008, 19, 1008-1014.
66. Mestecky, J., Tomana, M., Moldoveanu, Z., Julian, B. A. et al., Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press. Res. 2008, 31, 29-37.
67. Suzuki, H., Moldoveanu, Z., Hall, S., Brown, R. et al., IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J. Clin. Invest. 2008, 118, 629-639.
68. Novak, J., Julian, B. A., Tomana, M., Mestecky, J., IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin. Nephrol. 2008, 28, 78-87.
69. Hiki, Y., O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin. Exp. Nephrol. 2009, 13, 415-423.
70. Allen, A. C., Topham, P. S., Harper, S. J., Feehally, J., Leucocyte beta 1, 3 galactosyltransferase activity in IgA nephropathy. Nephrol. Dial. Transplant. 1997, 12, 701-706.
71. Qin, W., Zhou, Q., Yang, L. C., Li, Z. et al., Peripheral B lymphocyte beta1, 3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J. Intern. Med. 2005, 258, 467-477.
72. Qin, W., Zhong, X., Fan, J. M., Zhang, Y. J. et al., External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol. Dial. Transplant. 2008, 23, 1608-1614.
73. Inoue, T., Sugiyama, H., Hiki, Y., Takiue, K. et al., Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy. Clin. Immunol. 2010, 136, 447-455.
74. Yamada, K., Kobayashi, N., Ikeda, T., Suzuki, Y. et al., Down-regulation of core 1 beta1, 3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol. Dial. Transplant. 2010, 25, 3890-3897.
75. Xie, L. S., Qin, W., Fan, J. M., Huang, J. et al., The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy. Clin. Invest. Med. 2010, 33, E5-E13.
76. Li, G. S., Zhang, H., Lv, J. C., Shen, Y., Wang, H. Y., Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 2007, 71, 448-453.
77. Pirulli, D., Crovella, S., Ulivi, S., Zadro, C. et al., Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J. Nephrol. 2009, 22, 152-159.
78. Malycha, F., Eggermann, T., Hristov, M., Schena, F. P. et al., No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. Nephrol. Dial. Transplant. 2009, 24, 321-324.
79. Barratt, J., Feehally, J., IgA nephropathy. J. Am. Soc. Nephrol. 2005, 16, 2088-2097.
80. Springer, G. F., Desai, P. R., Cantrell, J. L., A rodent carcinoma and its lipidic extracts possess human blood group Tn-, T-, N- and M-specificities. Naturwissenschaften 1981, 68, 274-276.
81. Springer, G. F., Horton, R. E., Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J. Clin. Invest. 1969, 48, 1280-1291.
82. Novak, J., Julian, B. A., Tomana, M., Mesteck, J., Progress in molecular and genetic studies of IgA nephropathy. J. Clin. Immunol. 2001, 21, 310-327.
83. Leung, J. C., Tang, S. C., Chan, D. T., Lui, S. L., Lai, K. N., Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy. J. Clin. Lab. Anal. 2002, 16, 11-19.
84. Prokop, O., Uhlenbruck, G., [N-acetyl-D-galactosamine in tumor cell membranes: demonstration by means of Helix agglutinins]. Med. Welt 1969, 46, 2515-2519.
85. Konno, A., Hoshino, Y., Terashima, S., Motoki, R., Kawaguchi, T., Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin. Exp. Metastasis 2002, 19, 61-70.
86. Itzkowitz, S. H., Yuan, M., Montgomery, C. K., Kjeldsen, T. et al., Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989, 49, 197-204.
87. Orntoft, T. F., Harving, N., Langkilde, N. C., O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int. J. Cancer 1990, 45, 666-672.
88. Schumacher, U., Higgs, D., Loizidou, M., Pickering, R. et al., Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer 1994, 74, 3104-3107.
89. Mitchell, B. S., Schumacher, U., The use of the lectin Helix pomatia agglutinin (HPA) as a prognostic indicator and as a tool in cancer research. Histol. Histopathol. 1999, 14, 217-226.
90. Imada, T., Rino, Y., Hatori, S., Takahashi, M. et al., Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. Hepatogastroenterology 1999, 46, 208-214.
91. Wargovich, M. J., Chang, P., Velasco, M., Sinicrope, F. et al., Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci. Appl. Immunohistochem. Mol. Morphol. 2004, 12, 350-355.
92. Yuan, M., [The expression of Tn and S-Tn antigens in cancer and pre-malignant lesion of colorectal tissues by enzyme immunohistochemical method]. Zhonghua Bing Li Xue Za Zhi 1989, 18, 211-213.
93. Itzkowitz, S. H., Bloom, E. J., Lau, T. S., Kim, Y. S., Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut 1992, 33, 518-523.
94. Berriel, E., Hill, M., Barcia, J. J., Ubillos, L. et al., Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Oncol. Rep. 2005, 14, 219-227.
95. Araki, M., Araki, K., Biancone, L., Stamenkovic, I. et al., The role of E-selectin for neutrophil activation and tumor metastasis in vivo. Leukemia 1997, 11(Suppl 3), 209-212.
96. Izumi, Y., Kawamura, Y. J., Irimura, T., [Carbohydrate antigens in carcinoma invasion and metastasis]. Nippon Geka Gakkai Zasshi 1996, 97, 140-144.
97. Kim, Y. J., Borsig, L., Varki, N. M., Varki, A., P-selectin deficiency attenuates tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 1998, 95, 9325-9330.
98. Koukoulis, G. K., Patriarca, C., Gould, V. E., Adhesion molecules and tumor metastasis. Hum. Pathol. 1998, 29, 889-892.
99. Laidler, P., Litynska, A., Tumor cell N-glycans in metastasis. Acta Biochim. Pol. 1997, 44, 343-357.
100. Matsusako, T., Muramatsu, H., Shirahama, T., Muramatsu, T., Ohi, Y., A metastasis-associated antigen is present on a 60 kDa glycoprotein in transitional cell carcinoma of the human urinary bladder. Histochem. J. 1992, 24, 805-810.
101. Matsushita, Y., Kitajima, S., Goto, M., Tezuka, Y. et al., Selectins induced by interleukin-1beta on the human liver endothelial cells act as ligands for sialyl Lewis X-expressing human colon cancer cell metastasis. Cancer Lett. 1998, 133, 151-160.
102. McEver, R. P., Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj. J. 1997, 14, 585-591.
103. Meyer, T., Hart, I. R., Mechanisms of tumour metastasis. Eur. J. Cancer 1998, 34, 214-221.
104. Sass, P. M., The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Invest. 1998, 16, 322-328.
105. Tang, D. G., Honn, K. V., Adhesion molecules and tumor metastasis: an update. Invasion Metastasis 1994, 14, 109-122.
106. Yeatman, T. J., Nicolson, G. L., Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Semin. Surg. Oncol. 1993, 9, 256-263.
107. Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A. et al., Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 2007, 13, 1070-1077.
108. Higashi, N., Fujioka, K., Denda-Nagai, K., Hashimoto, S. et al., The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J. Biol. Chem. 2002, 277, 20686-20693.
109. Iida, S., Yamamoto, K., Irimura, T., Interaction of human macrophage C-type lectin with O-linked N-acetylgalactosamine residues on mucin glycopeptides. J. Biol. Chem. 1999, 274, 10697-10705.
110. Saeland, E., van Vliet, S. J., Backstrom, M., van den Berg, V. C. et al., The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol. Immunother. 2007, 56, 1225-1236.
111. van Vliet, S. J., van Liempt, E., Saeland, E., Aarnoudse, C. A. et al., Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int. Immunol. 2005, 17, 661-669.
112. Napoletano, C., Rughetti, A., Agervig Tarp, M. P., Coleman, J. et al., Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res. 2007, 67, 8358-8367.
113. Ogata, S., Maimonis, P. J., Itzkowitz, S. H., Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Cancer Res. 1992, 52, 4741-4746.
114. Byrd, J. C., Bresalier, R. S., Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004, 23, 77-99.
115. Lundstrom, M., Jeansson, S., Olofsson, S., Host cell-induced differences in the O-glycosylation of herpes simplex virus gC-1. II. Demonstration of cell-specific galactosyltransferase essential for formation of O-linked oligosaccharides. Virology 1987, 161, 395-402.
116. Steinman, R. M., Hawiger, D., Nussenzweig, M. C., Tolerogenic dendritic cells. Annual Rev. Immunol. 2003, 21, 685-711.
117. Geijtenbeek, T. B., van Vliet, S. J., Engering, A., t Hart, B. A., van Kooyk, Y., Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 2004, 22, 33-54.
118. Dausset, J., Moullec, J., Bernard, J., Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (Anti-Tn). Blood 1959, 14, 1079-1093.
119. Springer, G. F., Desai, P. R., Murthy, M. S., Scanlon, E. F., Human carcinoma-associated precursor antigens of the NM blood group system. J. Surg. Oncol. 1979, 11, 95-106.
120. Friedenreich, V., The Thomsen Hemagglutination Phenomenon, Vol. 1, Levin and Munskgaard, Copenhagen 1930.
121. Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W. et al., Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 2010, 70, 1306-1313.
122. Zamri, N., Masuda, N., Oura, F., Yajima, Y. et al., Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells. Biosci. Trends 2012, 6, 303-312.
123. Kubota, T., Matsushita, T., Niwa, R., Kumagai, I., Nakamura, K., Novel anti-Tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domain. Anticancer Res. 2010, 30, 3397-3405.
124. Ando, H., Matsushita, T., Wakitani, M., Sato, T. et al., Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo. Biol. Pharm. Bull. 2008, 31, 1739-1744.
125. Hubert, P., Heitzmann, A., Viel, S., Nicolas, A. et al., Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Cancer Res. 2011, 71, 5134-5143.
126. Agnese, D. M., Abdessalam, S. F., Burak, W. E., Jr., Arnold, M. W. et al., Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma. Ann. Surg. Oncol. 2004, 11, 197-202.
127. Rogers, B. E., Roberson, P. L., Shen, S., Khazaeli, M. B. et al., Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region. Cancer Biother. Radiopharm. 2005, 20, 502-513.
128. Fang, L., Holford, N. H., Hinkle, G., Cao, X. et al., Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patients. J. Clin. Pharmacol. 2007, 47, 227-237.
129. Shen, S., Forero, A., Meredith, R. F., LoBuglio, A. F., Biodistribution and dosimetry of In-111/Y-90-HuCC49DeltaCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma. Cancer Biother. Radiopharm. 2011, 26, 127-133.